期刊文献+

乌司他丁对小儿体外循环术后凝血功能的影响 被引量:4

Effects of ulinastatin on coagulation in children after cardiopulmonary bypass
原文传递
导出
摘要 目的观察乌司他丁对小儿体外循环(CPB)术后凝血功能的影响。方法 50例行心内直视修补术的单纯室间隔缺损患儿随机分为两组:乌司他丁组和对照组。乌司他丁组在CPB预充液中加入乌司他丁1.0×104U/kg。选择肝素化前、CPB结束后1 h、6 h、24 h共4个时间点,检测患儿的凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)等凝血指标。结果与对照组比较,乌司他丁组PT在CPB结束后1 h(18.7±0.7 s vs 15.5±0.5 s)及6 h(17.5±0.6 s vs 15.0±0.6 s)显著延长;APTT在CPB结束后6 h(38.7±3.1 s vs 35.3±3.1 s)及24 h(34.2±3.0 s vs 31.1±2.6 s)显著延长(P<0.05)。结论乌司他丁可引起患儿CPB术后PT及APTT延长,影响凝血状态。 Objective To study the effects of ulinastatin on coagulation in children who underwent open-heart surgery with eardiopulmonary bypass ( CPB ). Methods Fifty children who underwent open-heart surgery for ventrieular septal defect were randomly divided into two groups : ulinastatin treatment and control. Before CPB, ulinastatin ( 1.0 × 104 U/kg) was added to CPB priming fluid only in the ulinastatin treatment group. Activated partial thromboplasin time (APTT), prothrombin time (PT), thrombin time (Tr), fibrinogen and international normalized ratio (INR) were measured both before and at l hr, 6 hrs and 24 hrs after CPB. Results The PT in the ulinastatin group was more prolonged than in the control group at 1 hr after CPB (18.7±0.7 s vs 15.5±0.5 s) and6 hrs after CPB (17.5 ±0.6 s vs 15.0 ±0.6 s). The APTT in the ulinatatin group was also significantly more prolonged than in the control group at 6 hrs after CPB (38.7 ± 3.1 svs35.3±3.1 s) and24 hrs after CPB (34.2±3.0svs31. 1 ±.6 s). Conclusions Ulinastatin may prolong F'T and APTT after CPB, and thus affects coagulation in children.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2012年第4期279-281,共3页 Chinese Journal of Contemporary Pediatrics
关键词 乌司他丁 凝血功能 体外循环 儿童 Ulinastatin Coagulation Cardiopulmonary bypass Child
  • 相关文献

参考文献8

  • 1雷宾峰,陈铭伍,冼磊,何巍,冯旭,周华富.乌司他丁对心脏不停跳心内直视术机体免疫功能的影响[J].广西医学院学报,2008,18(3):381-383. 被引量:4
  • 2王妍心,陈胜阳.乌司他丁对儿童体外循环后肺的保护作用[J].实用儿科临床杂志,2011,26(11):846-847. 被引量:21
  • 3NishiyamaT,YokoyamaT,YamashitaK. Effects of a protease inhibitor,ulinastatin,on coagulation and fibrinolysis in abdominal surgery[J].Journal of Anesthesia,2006,(03):179-182.
  • 4Kawamura T,Inada K,Akasaka N,Wakusawa R. Ulinastatin reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery[J].Canadian Journal of anaesthesia-Journal canadien d anesthesie,1996,(5 Pt 1):456-460.
  • 5Pugia MJ,Valdes R Jr,Jortani SA. Bikunin (urinary trypsin inhibitor):structure,biological relevance,and measurement[J].Advances in Clinical Chemistry,2007.223-245.doi:10.1016/S0065-2423(07)44007-0.
  • 6Kobayashi H,Suzuki M,Hirashima Y,Terao T. The protease inhibitor bikunin,a novel anti-metastatic agent[J].Biological Chemistry,2003,(05):749-754.doi:10.1515/BC.2003.083.
  • 7Nii A,Morishita H,Yamakawa T,Matsusue T Hirose J Miura T. Design of variants of the second domain of urinary trypsin inhibitor (R-020) with increased factor Xa inhibitory activity[J].Journal of Biochemisitry,1994,(06):1107-1112.
  • 8Ten Cate H,Bauer KA,Levi M,Edgington TS Sublett RD Barzegar S. The activation of factor X and prothrombin by recombinant factor VⅡa in vivo is mediated by tissue factor[J].Journal of Clinical Investigation,1993,(03):1207-1212.

二级参考文献18

  • 1王奇,鞠名达,张威廉.体外循环心脏手术对机体免疫功能的影响[J].中华胸心血管外科杂志,1995,11(6):326-328. 被引量:14
  • 2[1]Misoph M,Babin-Ebell J,Schwender S.Response of the cellular immune system to cardiopulmonary bypass in vivo[J].Thorac Cardiovasc Surg,1997,45(5):217-223.
  • 3[2]Hall Rl,Smith MS,Rocker G.The systemic inflammatory response to cardiopulmonary bypass:pathophysiological,therapeutic,and pharmacological considerations[J].Anesth Analg,1997,85:766.
  • 4[3]Ma T,Kang C,Shao H.Protective effects of ulinastatin on proliferation and cytokine release of splenocytes from rats with severe acute pancreatitis[J].Eur Surg Res,2006,38(5):445-450.
  • 5[4]Mitsuhata H,Enzan K,Hasegawa J.Effects of ulinastatin on changes of plasma granulocyte elastase,myeloperoxidase and fibronectin during and after open heart surgery[J].Masui,1990,39(9):1 164-1 171.
  • 6[5]Sano T,M orita S,Tom inaga R.Adaptive immunity is severely impaired by open-heart surgery[J].Jpn J Thorac Cardiovasc Surg,2002,50(5):201-205.
  • 7[6]Tajima K,Yamamoto F,Kawazoe K.Cardiopulmonary bypass and cellular immunity:changes in lymphocyte subsets and natural killer cell activity[J].Ann Thorac Surg,1993,55(7):625-630.
  • 8[7]Jansen NJG,Van Oeveren W,Gn YI.Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass[J].Ann Thorac Surg,1995,54:744-748.
  • 9[8]Aosasa S,Ono S,Mochizuki H.Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes[J].Shock,2001,15(2):101-105.
  • 10[10]Sato Y,Ishikawa S,Otaki A.Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin.Inhibiting cytokines and postoperative organ injury[J].Jpn J Thorac Cardiovasc Surg,2000,48(7):428-434.

共引文献22

同被引文献69

  • 1唐芳,彭清雄.乌司他丁对脊柱手术患者围术期凝血功能的影响[J].医学临床研究,2013,30(6):1083-1085. 被引量:4
  • 2邹望远,郭曲练,蔡进,罗和国.乌司他丁对骨科病人血小板聚集及凝血功能的影响[J].中南大学学报(医学版),2004,29(5):569-571. 被引量:15
  • 3王照红.乌司他丁治疗急性胰腺炎的疗效观察[J].实用诊断与治疗杂志,2007,21(6):453-453. 被引量:12
  • 4Nakatani K, Takeshita S, Tsujimoto H, et al. Inhibitory effect of serine protease inhibitors on neutrophil mediated endothelial cell injury [ J ]. J Leukoc Biol, 2001,69:241.
  • 5Lin S D, Endo R, Sato A, et al. Plasma and urine levels of urinary tryp- sin inhibitor in patients with acute and fulminant hepatitis[ J ]. J Gastro- enterol Hepatol, 2002,17 : 140.
  • 6Kato Y, Kudo M, Shinkawa T, et al. Role of O-linked carbohy- drate of human urinary trypsin inhibitor on its lysosomal membrane- stabilizing property [ J]. Biochem Biophys Res Commun, 1998, 243 (2) : 377-383.
  • 7Uemura K, Murakami Y, Hayashidani Y, et al. Randomized clini- cal trial to assess the efficacy of ulinastatin for postoperative pancre- atitis following pancreaticoduodenectomy[ J]. J Surg Oncol, 2008, 98(5) :309-313.
  • 8Huang N, Wang F, Wang Y, et al. Ulinastatin improves survival of septic mice by suppressing inflammatory response and lymphocyte apoptosis[J]. J Surg Res, 2013,182(2) :296-302.
  • 9Tanaka R, Fujita M, Tsuruta R, et al. Urinary trypsin inhibitor suppresses excessive generation of superoxidc anion radical, systemic inflammation, oxidative stress, and endothelial injury in endotoxemic rats[ J]. Inflamm Res, 2010,59 (8) :597-606.
  • 10Xu CE, Zhang MY, Zou CW, et al. Evaluation of the pharmaco- logical function of ulinastatiu in experimental animals [ J ]. Mole- cules, 2012,17 ( 8 ) :9070-9080.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部